Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer

Tumour-associated macrophages (TAM) are involved in tumour angiogenesis and anti-tumour immune response. In colorectal cancer (CRC), an association of high microvascular density (MVD) and unfavourable prognosis has been reported by some investigators. However, heterogeneous patient groups were studied. We, therefore, analysed the correlation between TAM and MVD and the prognostic relevance of MVD, TAM and T lymphocyte infiltration for long-term survival in a homogeneous group of 70 patients with moderately differentiated cancers of the International Union Against Cancer (UICC) stages II and III, who did not receive chemotherapy. MVD was evaluated using immunohistochemistry with antibodies against CD34 and von Willebrand factor (vWF). TAM and T lymphocytes were visualised with antibodies against CD68 and CD3, respectively. Statistical analysis did not reveal a significant correlation between TAM and T lymphocyte numbers and MVD. Multivariate analysis of immunohistochemical data from all CRC patients and the subgroup of patients with UICC stage-II CRC identified TAM- and vWF-positive microvessel numbers as prognostically relevant markers. Low numbers of TAM- and high numbers of vWF-positive microvessels were associated with an unfavourable prognosis. In conclusion, TAM- and vWF-positive microvessel numbers may serve as independent prognostic markers for patients with UICC stage-II and -III CRC and may help to identify patients with an unfavourable prognosis.

[1]  Y. Maehara,et al.  Microvessel quantification and its possible relation with liver metastasis in colorectal cancer , 1996, Cancer.

[2]  N. Tanigawa,et al.  Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  宮園 浩平,et al.  Platelet-Derived Endothelial Cell Growth Factor , 2019 .

[4]  Zeng-chen Ma,et al.  Microvessel density of hepatocellular carcinoma: its relationship with prognosis , 1999, Journal of Cancer Research and Clinical Oncology.

[5]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[6]  Y Chiba,et al.  Changes of angiogenesis and tumor cell apoptosis during colorectal carcinogenesis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[8]  M. Kuwano,et al.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL‐1α , 2000 .

[9]  N. Kohno,et al.  Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer. , 2000, International journal of oncology.

[10]  A. Harris,et al.  Combined role of tumor angiogenesis, bcl‐2, and p53 expression in the prognosis of patients with colorectal carcinoma , 1999, Cancer.

[11]  P. Rogers,et al.  Macrophages and microvessel density in tumors of the ovary. , 1999, Gynecologic oncology.

[12]  西江 昭弘 Macrophage Infiltration and Heme Oxygenase-1 Expression Correlate with Angiogenesis in Human Gliomas , 2001 .

[13]  L. D. Tin,et al.  Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. , 2001, The American journal of pathology.

[14]  S. Kitano,et al.  Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  E. Scarpi,et al.  Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer. , 1999, Lung cancer.

[16]  G. Breier,et al.  The role of vascular endothelial growth factor in blood vessel formation. , 1996, Trends in cell biology.

[17]  M. Buyse,et al.  Should Dukes' B patients receive adjuvant therapy? A statistical perspective. , 2001, Seminars in oncology.

[18]  S. Fox,et al.  TUMOUR ANGIOGENESIS , 1996, The Journal of pathology.

[19]  S. Leurgans,et al.  Tumor Angiogenesis as a Predictor of Recurrence and Survival in Patients with Node‐Negative Colon Cancer , 1995, Annals of surgery.

[20]  T. Tamaya,et al.  Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. , 2000, Cancer research.

[21]  B. Zetter,et al.  Angiogenesis and tumor metastasis. , 1998, Annual review of medicine.

[22]  Chien-Nan Lee,et al.  Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma , 1999, Cancer.

[23]  F. Becker,et al.  Growth and metastasis of tumor in organ culture , 1963, Cancer.

[24]  I. Takanami,et al.  Tumor-Associated Macrophage Infiltration in Pulmonary Adenocarcinoma: Association with Angiogenesis and Poor Prognosis , 1999, Oncology.

[25]  W. Hohenberger,et al.  Adjuvant chemotherapy for stage II (Dukes' B) colon cancer: too early for routine use. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  Natale Cascinelli,et al.  Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma , 1996, Cancer.

[27]  G. Viale,et al.  Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. , 1995, Cancer research.

[28]  G. Fontanini,et al.  Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[29]  S. Hong,et al.  Tumor Angiogenesis as a Prognostic Predictor in Colorectal Carcinoma with Special Reference to Mode of Metastasis and Recurrence , 1998, Oncology.

[30]  S. Akiba,et al.  Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma , 1996, Cancer.

[31]  H Nagura,et al.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. , 1998, Cancer research.

[32]  A. Konstantinidou,et al.  A morphometric study of neovascularization in colorectal carcinoma , 1998, Cancer.

[33]  R. Whitehouse,et al.  Tumor angiogenesis in stage II colorectal carcinoma: association with survival. , 1998, American journal of clinical pathology.

[34]  M. Kuwano,et al.  Biological implications of macrophage infiltration in human tumor angiogenesis , 1999, Cancer Chemotherapy and Pharmacology.

[35]  J. Moul,et al.  CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. , 1998, The Journal of urology.

[36]  K. Alitalo,et al.  Tie receptors: new modulators of angiogenic and lymphangiogenic responses , 2001, Nature Reviews Molecular Cell Biology.

[37]  R. Muraoka,et al.  Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma , 1997, Cancer.

[38]  S. Marsoni Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. , 2001, Seminars in oncology.

[39]  S. Abe,et al.  Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  A. Kaider,et al.  Prognostic significance of tumor angiogenesis in endometrial cancer. , 1999, Obstetrics and gynecology.

[41]  L. Fielding,et al.  PREDICTION OF OUTCOME AFTER CURATIVE RESECTION FOR LARGE BOWEL CANCER , 1986, The Lancet.

[42]  J. Harmey,et al.  Phenotyping of immune cell infiltrates in breast and colorectal tumours. , 1999, Immunological investigations.

[43]  B. Davidson,et al.  Macrophage infiltration and angiogenesis in cervical squamous cell carcinomaclinicopathologic correlation , 1999, Acta obstetricia et gynecologica Scandinavica.

[44]  E. PeñaydelaPeña,et al.  [Cancer of the rectum]. , 1955, Revista de sanidad militar.

[45]  Joe W. Gray,et al.  The Molecular Basis of Cancer , 1985 .

[46]  R K Jain,et al.  Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. , 1992, Cancer research.

[47]  R. Weichselbaum,et al.  Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. , 1996, Journal of the National Cancer Institute.

[48]  D. Cheresh,et al.  Cell adhesion and angiogenesis. , 1996, Trends in cell biology.

[49]  J DeMiguel,et al.  Cancer of the colon , 1973 .

[50]  S. Kumar,et al.  Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. , 1999, Cancer research.

[51]  Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. , 1997, Trends in cell biology.

[52]  R. Muraoka,et al.  Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. , 1998, The Annals of thoracic surgery.

[53]  R. Muraoka,et al.  Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. , 1997, Cancer research.

[54]  A. Harris,et al.  Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer , 2000, The Journal of pathology.

[55]  T. Tsuruo,et al.  Expression of platelet‐derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma , 2000, Cancer.

[56]  A. Halpern,et al.  Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.

[57]  V. Kosma,et al.  Prognostic value of tumour‐infiltrating lymphocytes (TILs) in colorectal cancer , 1997, The Journal of pathology.

[58]  J L MADDEN,et al.  CANCER OF THE COLON. , 1964, American journal of surgery.

[59]  N. MacDonald,et al.  Angiostatin and Endostatin: Endogenous Inhibitors of Tumor Growth , 2004, Cancer and Metastasis Reviews.

[60]  V. Kosma,et al.  Lymphocyte infiltrates as a prognostic variable in female breast cancer. , 1992, European journal of cancer.